红细胞沉降率与C反应蛋白的变化能否指导两阶段关节置换翻修术的再植入时机?
回顾性分析2005至2014年两家关节置换登记处291例接受两阶段翻修全髋或全膝关节置换术的患者,评估从切除前到再植入前红细胞沉降率(ESR)和C反应蛋白(CRP)的变化百分比能否判断感染根除及再植入时机,并分析致病菌类型与血清学指标的关系。结果显示ΔESR和ΔCRP百分比对复发或持续感染的诊断准确性差,与再感染风险无关,作者认为再植入决策需综合考虑多种因素而非依赖特定血清学阈值变化。
要点
- ΔESR(AUC=0.581)和ΔCRP(AUC=0.539)百分比是复发或持续感染的差劣标志物。
- 感染根除者与再感染者之间ΔESR和ΔCRP百分比无显著差异(p=0.540和p=0.634)。
- 切除前ESR在耐药菌感染患者中高于非耐药菌感染者(中位数69 vs 55,p=0.020)。
核心结论
- 在控制ASA分级后,两阶段再植入前后血清ESR和CRP的变化百分比与再感染风险无关。
- 尽管再植入前血清学恢复正常不常发生,ΔESR和ΔCRP对确定再植入时机不提供额外诊断准确性。
- 切除前后的血清学值与耐药或非耐药病原体无有意义的关系。
- 再植入决策必须考虑多种变量,而非血清炎症标志物的特定阈值变化。
研究设计与样本
- 回顾性研究,纳入2005至2014年两家机构关节置换登记处接受两阶段翻修全髋或全膝关节置换术的300例患者,其中9例失访,分析291例。
- 血清ESR和CRP在切除前和完成6周静脉抗生素治疗及药物洗脱间隔器后两个时间点记录。
- 根据Musculoskeletal Infection Society标准,通过电子病历回顾至少2年,记录感染病原体、翻修手术及复发/持续感染。
- 采用受试者工作特征曲线分析,控制美国麻醉医师协会(ASA)分级。
- 证据等级:III级,诊断性研究。
主要发现
- 291例中48例(16%)因复发或持续感染接受翻修手术,31例(10%)因非感染原因翻修。
- ΔESR的AUC为0.581,ΔCRP的AUC为0.539,两者百分比均为复发或持续感染的差劣标志物。
- 感染未复发者中位ΔESR百分比为50%(IQR 17%-77%),再感染者中位ΔESR百分比为59%(IQR 29%-78%),p=0.540。
- 感染未复发者中位ΔCRP百分比为77%(IQR 47%-92%),再感染者中位ΔCRP百分比为79%(IQR 46%-95%),p=0.634。
- 耐药菌感染者切除前ESR水平高于非耐药菌感染者(中位数69 vs 55,p=0.020)。
关键数值与推荐
- ΔESR的AUC=0.581,ΔCRP的AUC=0.539,提示诊断准确性差。
- 感染未复发者与再感染者ΔESR百分比中位数分别为50%和59%,p=0.540。
- 感染未复发者与再感染者ΔCRP百分比中位数分别为77%和79%,p=0.634。
- 耐药菌感染与非耐药菌感染者切除前ESR中位数分别为69和55,p=0.020。
临床怎么用
- 作者认为,再植入决策必须考虑多种变量,而非血清炎症标志物的特定阈值变化。
- 作者指出,ΔESR和ΔCRP不提供额外诊断准确性以确定再植入时机。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two-stage reimplantation arthroplasty is a commonly used approach for treating chronic periprosthetic joint infections. A prereimplantation threshold value of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) to determine infection eradication and the proper timing of reimplantation remains ill defined. We theorized that rather than a specific numeric threshold, a percentage of improvement in these serology markers might improve diagnostic accuracy in determining the timing of reimplantation. QUESTION/PURPOSES: We investigated if (1) the percent, or delta, change in ESR and CRP values from preresection to prereimplantation ([INCREMENT]ESR, [INCREMENT]CRP) is a useful marker of infection eradication and (2) whether the initial PJI causative organism (resistant, nonresistant, or culture-negative) is associated with serum ESR and CRP values before and after treatment with an antibiotic spacer and parenteral antibiotic therapy. METHODS: We retrospectively reviewed 300 patients, nine of whom were lost to followup, treated with a two-stage revision THA or TKA protocol between 2005 and 2014 from two separate institutional arthroplasty registries. Serum ESR and CRP values were recorded at two designated points: (1) preresection and (2) after 6 weeks of intravenous antibiotic therapy with a drug-eluting spacer and completion of an organism-specific intravenous antibiotic regimen. Patient records were reviewed electronically for causative species of infection, revision surgeries, and recurrent/persistent infection based on Musculoskeletal Infection Society criteria for a minimum of 2 years. Forty-eight of 291 patients (16%) underwent a revision procedure for recurrent or persistent infection, whereas 31 patients (10%) were revised for noninfectious reasons. The [INCREMENT]ESR, [INCREMENT]CRP, culture results, and patient demographics were recorded and analyzed with receiver operator curves controlling for American Society of Anesthesiologists (ASA) class. RESULTS: Receiver operator characteristic area under the curves (AUC) demonstrated that both the [INCREMENT]ESR (AUC = 0.581) and [INCREMENT]CRP (AUC = 0.539) percentages were poor markers of recurrent or persistent infection. When comparing preresection with prereimplantation values, the median percent [INCREMENT]ESR was 50% (interquartile range [IQR], 17%-77%) for those patients who remained infection-free versus 59% (IQR, 29%-78%) for those who developed reinfection (p = 0.540). The median percent [INCREMENT]CRP was 77% (IQR, 47%-92%) for those patients who remained infection-free versus 79% (IQR, 46%-95%) for those who experienced reinfection (p = 0.634). Although no significant differences were found between organism type and CRP values at the two time points, the preresection ESR level was higher in patients infected with resistant bacteria (median, 69; IQR, 60%-85%) compared with nonresistant organisms (median, 55; IQR, 33%-83%; p = 0.020). CONCLUSIONS: The percent change in serum ESR and CRP inflammatory markers before and after two-stage reimplantation for PJI was not associated with reinfection risk when controlling for ASA class. Although a return to normal serology infrequently occurs before reimplantation, [INCREMENT]ESR and [INCREMENT]CRP provide no additional diagnostic accuracy to determine the timing of reimplantation. Furthermore, the pre- and postresection serology values have no meaningful relationship to resistant or nonresistant pathogens. Decisions for reimplantation must take into account multiple variables rather than a specific threshold change in serum inflammatory markers. LEVEL OF EVIDENCE: Level III, diagnostic study.
引用
- Stambough JB, Curtin BM, Odum SM, et al. Does Change in ESR and CRP Guide the Timing of Two-stage Arthroplasty Reimplantation? Clin Orthop Relat Res. 2019. PMID: 30566107. doi:10.1097/01.blo.0000533618.31937.45
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。